Eli Lilly Plans $2.5 Billion Plant in Germany to Meet Rising Demand
17 Novembro 2023 - 11:00AM
Dow Jones News
By Colin Kellaher
Eli Lilly plans to build a new $2.5 billion manufacturing site
in Germany to help meet growing demand for its burgeoning diabetes
and obesity franchise.
The Indianapolis drugmaker on Friday said the plant in Alzey,
which will employ up to 1,000 workers and is slated to be
operational beginning in 2027, will expand its injectable product
and device manufacturing network.
Eli Lilly earlier this month won U.S. Food and Drug
Administration approval expanding the use of its diabetes drug
Mounjaro to include the treatment of obesity. The company will sell
the drug under the name Zepbound for chronic weight management.
Analysts polled by FactSet expect Eli Lilly's annual global
sales in both diabetes and obesity to reach $11.8 billion in 2025,
up from $4.5 billion this year.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
November 17, 2023 08:45 ET (13:45 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Eli Lilly (NYSE:LLY)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Eli Lilly (NYSE:LLY)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
